Caution is raised with substantial selling of Supernus Pharm...

Caution is raised with substantial selling of Supernus Pharmaceuticals stock by key insiders and lack of buying in the past year. Insider ownership isn't high, indicating alignment with other shareholders. Evaluate carefully before purchasing due to these factors.